Related links
CHESTERFIELD, MO (KTVI-FOX2now.com) -
Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations. The plan, announced Monday, will bring the closure of six of their 20 research facilities, reorganize and consolidate others, and cut the jobs of up to 2,000 scientists and laboratory technicians. Pfizer is selling it's St. Louis operations at the Chesterfield Village Research Center back to original owner Monsanto Company for $435 million.
The sale includes 250 labs, 122 plant growth chambers, and a 1.3 million square foot facility. Along with the sale, 600 employees of Pfizer will be laid off from the facility. Pfizer will be working with those laid off, to see if they can be placed in other company operations globally. Approximately 1000 workers are at the Chesterfield location.
Pfizer was recently forced to pay the largest criminal fine in history. It took $2 billion dollars to settle charges the company illegally marketed pain reliever "Bextra" and other drugs to treat conditions they were not approved for.
Pfizer pulled Bextra off the market in 2005 after it was linked to a rare skin disease.
The sale includes 250 labs, 122 plant growth chambers, and a 1.3 million square foot facility. Along with the sale, 600 employees of Pfizer will be laid off from the facility. Pfizer will be working with those laid off, to see if they can be placed in other company operations globally. Approximately 1000 workers are at the Chesterfield location.
Pfizer was recently forced to pay the largest criminal fine in history. It took $2 billion dollars to settle charges the company illegally marketed pain reliever "Bextra" and other drugs to treat conditions they were not approved for.
Pfizer pulled Bextra off the market in 2005 after it was linked to a rare skin disease.
